X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

TARA

Closed

Protara Therapeutics Inc

2.8
-0.2 (-6.60%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.03
Day's Range: 2.79 - 3.095
Send
When Written:
 
3.04
Protara Therapeutics Inc. is a biopharmaceutical company that focuses on developing and commercializing therapies for rare and specialty diseases. The company's lead product candidate, TARA-002, is a potential treatment for lymphatic malformations, a rare and debilitating disease that affects the lymphatic system. Protara is also developing TARA-001, a potential treatment for intravenous iron deficiency anemia, and TARA-003, a potential treatment for pulmonary arterial hypertension. The company was founded in 2013 and is headquartered in New York, NY.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.15
X